605077 Stock Overview
Zhejiang Huakang Pharmaceutical Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Zhejiang Huakang Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥14.88 |
| 52 Week High | CN¥20.12 |
| 52 Week Low | CN¥11.85 |
| Beta | 0.61 |
| 1 Month Change | -5.76% |
| 3 Month Change | 21.17% |
| 1 Year Change | -15.97% |
| 3 Year Change | -33.96% |
| 5 Year Change | n/a |
| Change since IPO | -49.01% |
Recent News & Updates
A Look At The Fair Value Of Zhejiang Huakang Pharmaceutical Co., Ltd. (SHSE:605077)
Dec 19
Zhejiang Huakang Pharmaceutical's (SHSE:605077) Anemic Earnings Might Be Worse Than You Think
Nov 02Zhejiang Huakang Pharmaceutical Co., Ltd.'s (SHSE:605077) Earnings Are Not Doing Enough For Some Investors
Oct 14Recent updates
A Look At The Fair Value Of Zhejiang Huakang Pharmaceutical Co., Ltd. (SHSE:605077)
Dec 19Zhejiang Huakang Pharmaceutical's (SHSE:605077) Anemic Earnings Might Be Worse Than You Think
Nov 02Zhejiang Huakang Pharmaceutical Co., Ltd.'s (SHSE:605077) Earnings Are Not Doing Enough For Some Investors
Oct 14Zhejiang Huakang Pharmaceutical (SHSE:605077) Will Want To Turn Around Its Return Trends
Sep 26Improved Earnings Required Before Zhejiang Huakang Pharmaceutical Co., Ltd. (SHSE:605077) Shares Find Their Feet
Jul 02Zhejiang Huakang Pharmaceutical (SHSE:605077) May Have Issues Allocating Its Capital
May 28We Think That There Are Some Issues For Zhejiang Huakang Pharmaceutical (SHSE:605077) Beyond Its Promising Earnings
May 02Shareholder Returns
| 605077 | CN Food | CN Market | |
|---|---|---|---|
| 7D | -6.9% | -5.6% | -3.5% |
| 1Y | -16.0% | 4.1% | 10.9% |
Return vs Industry: 605077 underperformed the CN Food industry which returned 4.1% over the past year.
Return vs Market: 605077 underperformed the CN Market which returned 10.9% over the past year.
Price Volatility
| 605077 volatility | |
|---|---|
| 605077 Average Weekly Movement | 7.9% |
| Food Industry Average Movement | 7.3% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 605077 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 605077's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 1,350 | Deshui Chen | www.huakangpharma.com |
Zhejiang Huakang Pharmaceutical Co., Ltd. engages in the research, production, and sale of polyols and starch sugar worldwide. It offers xylitol, a polyol with close to sugar sweetness; sorbitol, a sugar alcohol white crystal powder or colorless liquid; maltitol, a sugar alcohol; xylose that is used in xylitol production; and L-arabinos, which can be used as sucrose replacement or additives. The company was founded in 2001 and is based in Quzhou, China.
Zhejiang Huakang Pharmaceutical Co., Ltd. Fundamentals Summary
| 605077 fundamental statistics | |
|---|---|
| Market cap | CN¥4.38b |
| Earnings (TTM) | CN¥283.61m |
| Revenue (TTM) | CN¥2.85b |
15.6x
P/E Ratio1.6x
P/S RatioIs 605077 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 605077 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.85b |
| Cost of Revenue | CN¥2.23b |
| Gross Profit | CN¥617.71m |
| Other Expenses | CN¥334.10m |
| Earnings | CN¥283.61m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.95 |
| Gross Margin | 21.70% |
| Net Profit Margin | 9.96% |
| Debt/Equity Ratio | 66.1% |
How did 605077 perform over the long term?
See historical performance and comparisonDividends
3.6%
Current Dividend Yield56%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 11:51 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Zhejiang Huakang Pharmaceutical Co., Ltd. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Citic Securities Co., Ltd. |
| Zhe Wang | Citic Securities Co., Ltd. |